[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Test product- LDRT (Administered as 50 \u00e2?? 100 cGy): The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.Control Intervention1: Standard of Care: The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Test product- LDRT (Administered as 50 \u00e2?? 100 cGy): The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care: The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 746, "treatment_name": "Low dose radiation therapy", "treatment_type": "Radiation therapy", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Test product- LDRT (Administered as 50 \u00e2?? 100 cGy): The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.Control Intervention1: Standard of Care: The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Test product- LDRT (Administered as 50 \u00e2?? 100 cGy): The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care: The study will be conducted with 100 patients. These 100 patients will be assessed for safety and efficacy outcomes till Day 28 post the first dose of treatment administration.Radiation Safety and efficacy data will be submitted to the regulatory authorities. LDRT + Standard of Care or Standard of Care only for 5 days. The study includes up to -4 to Day 1 of screening period and day 1 of treatment period and follow up of 28days.The total duration of study participation will be of 28 (\u00c2\u00b12) days from the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]